Wanbury's Patalganga site clears Korea FDA inspection with zero observations

Patalganga plant received zero observation from USFDA earlier

Pfizer drug delivers breakthrough in late-stage blood cancer trial

Patients receiving ELREXFIO largely remained free from disease progression during the interim analysis

Gen Z split on AI as global study reveals rising tech optimism

Health innovations are viewed more positively than food and agricultural technologies

Monitra Health raises fresh funding to scale upBeat® cardiac monitoring platform globally

The medtech firm strengthens its full-stack remote cardiac monitoring platform, achieves 11x revenue growth, and advances its global expansion plans

Apollo TeleHealth expands integrated healthcare services to Sri City in Tamil Nadu

New medical and wellness centre combines on-site care with telehealth to support industrial workforce and surrounding communities

Ferrotec launches fast & flexible DNA/RNA isolation kit aimed at streamlining lab workflows

Pfizer locks in long runway for blockbuster heart drug after key patent settlements

The deals, tied to cases in the US District Court for the District of Delaware, effectively extend US patent protection for VYNDAMAX until June 1, 2031

Exciva initiates Phase 2/3 SERENADA trial for Alzheimer’s agitation therapy

The company doses first patient in US study of Deraphan, as Dolby Ventures joins €53M Series B to support neuropsychiatric innovation

Lilly buys Ajax Therapeutics for up to $2.3 billion to target rare blood cancers

Ajax's lead program, AJ1-11095, is a first-in-class Type II JAK2 inhibitor currently in Phase 1 clinical development, with first proof-of-concept clinical data to be presented later in 2026

Concept Medical unveils promising 3-year data for sirolimus balloon therapy

The results signal shift beyond paclitaxel-coated balloon (PCB) angioplasty in femoropopliteal artery disease